Prevalence and Patterns of Soft Tissue Metastasis: Detection with True Whole-body F-18 FDG PET/CT

Overview

Journal BMC Med Imaging

Publisher Biomed Central

Specialty Radiology

Date 2007 Dec 14

PMID 18076764

Citations 33

Authors

Nghi C Nguyen

Bassem T Chaar

Medhat M Osman

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this retrospective study was to report the prevalence and patterns of soft tissue (ST) metastasis detected with true whole-body (TWB) F-18 FDG PET/CT acquired from the top of the skull through the bottom of the feet and to compare such findings to that of the typically acquired skull-base to upper-thigh, thus limited whole-body (LWB) field of view (FOV).

Methods: TWB FDG-PET/CT scans were performed in 500 consecutive cancer patients. Suspected ST metastasis was verified by correlation with surgical pathology, other imaging modalities, or clinical follow-up.

Results: Nine out of 500 patients (1.8 %) had ST metastasis with a prevalence of 4/41 (9.8%) for melanoma, 2/60 (3.3%) for lung carcinoma, 2/88 (2.3%) for lymphoma and 1/13 (77%) for esophageal cancer. Those nine patients had a total of 41 ST lesions: 22 lesions within and 19 outside of LWB FOV. Of those 41 lesions, 19 (46%) were subcutaneous and 22 (54%) were muscular lesions. The presence of ST metastasis neither changed the staging nor the treatment in any of these patients. However, the ST lesions provided a biopsy site in 4 of the 9 patients (44%). Seven out of nine studied patients died of their disease within 1-22 months after ST metastasis was diagnosed.

Conclusion: The detection of ST metastasis may have prognostic implications, provide more accessible biopsy sites and help avoid invasive procedures. A LWB scanning may underestimate the true extent of ST metastasis since a significant percentage of ST metastasis (46%) occurred outside the typical LWB FOV.

Citing Articles

Metastatic Bladder Urothelial Carcinoma Masquerading as Myositis.

Dilli C, Mi W, Guzman M J Med Cases. 2024; 15(7):130-135.

PMID: 38993807 PMC: 11236334. DOI: 10.14740/jmc4236.

Ultrasound and CT findings of subcutaneous metastases in trunk and pelvis: a comprehensive analysis.

Kim Y, Kim H, Lee J, Yoon Y Skeletal Radiol. 2024; 53(12):2665-2675.

PMID: 38727740 DOI: 10.1007/s00256-024-04704-5.

Surgical resection of soft tissue metastasis in cancers: A single-center study of 77 cases over a 7-year period.

Ye Q, Hu T, Sun Z, Xu P, Wang C, Sun Y Cancer Med. 2023; 12(24):22081-22090.

PMID: 38083869 PMC: 10757142. DOI: 10.1002/cam4.6808.

An Atypical Presentation of Soft Tissue Metastasis in a Patient With Lung Cancer.

Tvedten E, Deak Z, Schwartz B, Rice A Cureus. 2021; 13(7):e16294.

PMID: 34405061 PMC: 8352797. DOI: 10.7759/cureus.16294.

Challenge of treating skeletal muscle metastasis during the COVID-19 pandemic in a low-resource setting.

Casas M, Rosario M, Battad G, Mercado A, Hermogenes T, Hernandez A Ecancermedicalscience. 2021; 15:1235.

PMID: 34221118 PMC: 8225338. DOI: 10.3332/ecancer.2021.1235.

References

Damron T, Heiner J . Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature. Ann Surg Oncol. 2000; 7(7):526-34. DOI: 10.1007/s10434-000-0526-7. View

Hidaka T, Ishii Y, Kitamura S . Clinical features of skin metastasis from lung cancer. Intern Med. 1996; 35(6):459-62. DOI: 10.2169/internalmedicine.35.459. View

Swetter S, Geller A, Kirkwood J . Melanoma in the older person. Oncology (Williston Park). 2004; 18(9):1187-96. View

Schwartz R . Cutaneous metastatic disease. J Am Acad Dermatol. 1995; 33(2 Pt 1):161-82; quiz 183-6. DOI: 10.1016/0190-9622(95)90231-7. View

Pfannenberg C, Aschoff P, Schanz S, Eschmann S, Plathow C, Eigentler T . Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007; 43(3):557-64. DOI: 10.1016/j.ejca.2006.11.014. View

Rohren E, Provenzale J, Barboriak D, Coleman R . Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology. 2003; 226(1):181-7. DOI: 10.1148/radiol.2261010920. View

Czernin J, Allen-Auerbach M, Schelbert H . Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007; 48 Suppl 1:78S-88S. View

Sridhar K, Rao R, Kunhardt B . Skeletal muscle metastases from lung cancer. Cancer. 1987; 59(8):1530-4. DOI: 10.1002/1097-0142(19870415)59:8<1530::aid-cncr2820590824>3.0.co;2-h. View

Antoch G, Vogt F, Freudenberg L, Nazaradeh F, Goehde S, Barkhausen J . Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003; 290(24):3199-206. DOI: 10.1001/jama.290.24.3199. View

10.

Balch C, Soong S, Gershenwald J, Thompson J, Reintgen D, Cascinelli N . Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001; 19(16):3622-34. DOI: 10.1200/JCO.2001.19.16.3622. View

11.

Kransdorf M, Jelinek J, Moser Jr R, Utz J, Brower A, Hudson T . Soft-tissue masses: diagnosis using MR imaging. AJR Am J Roentgenol. 1989; 153(3):541-7. DOI: 10.2214/ajr.153.3.541. View

12.

Katzner M, Sur H, Babin S, SCHVINGT E . [Surgery of bone metastases in the limbs. A series of 254 operated metastases. Current attitude]. J Chir (Paris). 1983; 120(1):33-9. View

13.

von Schulthess G, Steinert H, Hany T . Integrated PET/CT: current applications and future directions. Radiology. 2006; 238(2):405-22. DOI: 10.1148/radiol.2382041977. View

14.

Lardinois D, Weder W, Hany T, Kamel E, Korom S, Seifert B . Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003; 348(25):2500-7. DOI: 10.1056/NEJMoa022136. View

15.

Browne J, de Pierro A . A row-action alternative to the EM algorithm for maximizing likelihood in emission tomography. IEEE Trans Med Imaging. 1996; 15(5):687-99. DOI: 10.1109/42.538946. View

16.

Spencer P, Helm T . Skin metastases in cancer patients. Cutis. 1987; 39(2):119-21. View

17.

HABERMANN E, Lopez R . Metastatic disease of bone and treatment of pathological fractures. Orthop Clin North Am. 1989; 20(3):469-86. View

18.

Herring Jr C, Harrelson J, Scully S . Metastatic carcinoma to skeletal muscle. A report of 15 patients. Clin Orthop Relat Res. 1999; (355):272-81. DOI: 10.1097/00003086-199810000-00029. View

19.

Delbeke D, Coleman R, Guiberteau M, Brown M, Royal H, Siegel B . Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006; 47(5):885-95. View

20.

Balch C, Buzaid A, Soong S, Atkins M, Cascinelli N, Coit D . Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001; 19(16):3635-48. DOI: 10.1200/JCO.2001.19.16.3635. View